Prostaglandin G/H synthase 2
Named enzymes, including the metabolising cytochromes and the monoamine oxidases.
- Measurements
- 26
- Compounds
- 13
- Binding constants
- 7
- Median pX
- —
I · Identity
What this target is
Its function as UniProt states it, where in a cell the protein is found, and which cell types and tissues transcribe its gene.
Prostaglandin G/H synthase 2
Dual cyclooxygenase and peroxidase in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response11939906,16373578,19540099,22942274,26859324,27226593,7592599,7947975,9261177. The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide prostaglandin H2 (PGH2), the precursor of all 2-series prostaglandins and thromboxanes16373578,22942274,26859324,27226593,7592599,7947975,9261177. This complex transformation is initiated by abstraction of hydrogen at carbon 13 (with S-stereochemistry), followed by insertion of molecular O2 to form the endoperoxide bridge between carbon 9 and 11 that defines prostaglandins. The insertion of a second molecule of O2 (bis-oxygenase activity) yields a hydroperoxy group in PGG2 that is then reduced to PGH2 by two electrons16373578,22942274,26859324,27226593,7592599,7947975,9261177. Similarly catalyzes successive cyclooxygenation and peroxidation of dihomo-gamma-linoleate (DGLA, C20:3(n-6)) and eicosapentaenoate (EPA, C20:5(n-3)) to corresponding PGH1 and PGH3, the precursors of 1- and 3-series prostaglandins11939906,19540099. In an alternative pathway of prostanoid biosynthesis, converts 2-arachidonoyl lysophopholipids to prostanoid lysophopholipids, which are then hydrolyzed by intracellular phospholipases to release free prostanoids27642067. Metabolizes 2-arachidonoyl glycerol yielding the glyceryl ester of PGH2, a process that can contribute to pain response22942274. Generates lipid mediators from n-3 and n-6 polyunsaturated fatty acids (PUFAs) via a lipoxygenase-type mechanism. Oxygenates PUFAs to hydroperoxy compounds and then reduces them to corresponding alcohols11034610,11192938,9048568,9261177. Plays a role in the generation of resolution phase interaction products (resolvins) during both sterile and infectious inflammation12391014. Metabolizes docosahexaenoate (DHA, C22:6(n-3)) to 17R-HDHA, a precursor of the D-series resolvins (RvDs)12391014. As a component of the biosynthetic pathway of E-series resolvins (RvEs), converts eicosapentaenoate (EPA, C20:5(n-3)) primarily to 18S-HEPE that is further metabolized by ALOX5 and LTA4H to generate 18S-RvE1 and 18S-RvE221206090. In vascular endothelial cells, converts docosapentaenoate (DPA, C22:5(n-3)) to 13R-HDPA, a precursor for 13-series resolvins (RvTs) shown to activate macrophage phagocytosis during bacterial infection26236990. In activated leukocytes, contributes to oxygenation of hydroxyeicosatetraenoates (HETE) to diHETES (5,15-diHETE and 5,11-diHETE)22068350,26282205. Can also use linoleate (LA, (9Z,12Z)-octadecadienoate, C18:2(n-6)) as substrate and produce hydroxyoctadecadienoates (HODEs) in a regio- and stereospecific manner, being (9R)-HODE ((9R)-hydroxy-(10E,12Z)-octadecadienoate) and (13S)-HODE ((13S)-hydroxy-(9Z,11E)-octadecadienoate) its major products (By similarity). During neuroinflammation, plays a role in neuronal secretion of specialized preresolving mediators (SPMs) 15R-lipoxin A4 that regulates phagocytic microglia (By similarity)
Quoted from UniProt’s FUNCTION annotation for P35354 (reviewed). The superscript numbers are UniProt’s own PubMed citations, kept in the sentence and in order, each linking to the paper it names.
What it acts with
STRING’s highest-confidence human functional partners. The combined score mixes several kinds of evidence, so each channel is shown separately — a partner supported by experiment is a different claim from one supported only by text mining, and for a receptor this is where its coupling appears as evidence rather than as assertion.
Where it sits in the cell
- Vesicles
- Cytosoladditional
Human Protein Atlas, by antibody immunofluorescence in cell lines — a different assay from the expression figures below, which are RNA.
UniProt, curated Microsome membrane · Endoplasmic reticulum membrane · Nucleus inner membrane · Nucleus outer membrane
Expression by cell type
Single cell type RNA, the 8 highest of those the Human Protein Atlas reports for this gene. Transcript, not protein, and a cell type rather than a tissue.
- Neutrophils1,508.5 nCPM
- Epididymal basal cells666.1 nCPM
- monocytes659 nCPM
- Urothelial cells450.9 nCPM
- Mast cells391 nCPM
- Ocular epithelial cells381.7 nCPM
- Alveolar cells type 1296.2 nCPM
- Fibroblasts184.6 nCPM
Expression by tissue
The tissues this gene is enriched in, by consensus RNA. A tissue absent from this list is one the Atlas does not call specific for this gene, which is not the same as absent from it.
- urinary bladder151.3 nTPM
- seminal vesicle120.2 nTPM
- bone marrow110.4 nTPM
II · Anatomy
Where the gene is transcribed
The same two atlases the compound plates use, asked about this gene alone. Brain on the left, peripheral and autonomic tissues on the right.
Brain
basal ganglia: drawn as the caudate nucleus, putamen and globus pallidus.
Measured but not drawn — this anatomogram has no outline for them: spinal cord 3.5, pituitary gland 2.8, midbrain 1.3, retina 0.2.
Body
Square-root ramp · shared scale across both plates
Shading is transcript level — not affinity, and not affinity combined with expression. Outlined but unshaded organs hold none of PTGS2 transcript above the atlas’s detection threshold. Anatomy from EMBL-EBI Anatomogram (Apache License 2.0); regions identified by Uberon (uberon.org), CC BY 3.0.
Brain · 10
- cerebral cortex5.7 nTPM
- spinal cord3.5 nTPM
- pituitary gland2.8 nTPM
- midbrain1.3 nTPM
- hippocampal formation1.1 nTPM
- amygdala1.0 nTPM
- hypothalamus0.9 nTPM
- basal ganglia0.7 nTPM
- cerebellum0.2 nTPM
- retina0.2 nTPM
Peripheral and autonomic · 16
- urinary bladder151.3 nTPM
- lung34.5 nTPM
- colon13.9 nTPM
- stomach 113.6 nTPM
- smooth muscle11.4 nTPM
- heart muscle11.3 nTPM
- kidney9.3 nTPM
- adrenal gland7.5 nTPM
- liver7.4 nTPM
- small intestine3.3 nTPM
- thyroid gland3.0 nTPM
- spleen2.7 nTPM
- duodenum2.4 nTPM
- pancreas2.1 nTPM
- salivary gland1.0 nTPM
- skeletal muscle0.2 nTPM
Transcript is not protein. These are RNA levels for PTGS2, shaded on √nTPM so that a three-order range stays legible — on a linear ramp every region but the strongest would read as blank, which looks like absence rather than less. A region carrying no shading is one the atlas reports no consensus value for, not one where the gene is silent. And a gene being transcribed somewhere is not evidence that any compound reaches it. Human Protein Atlas, RNA expression, nTPM (normalized transcripts per million), consensus tissue dataset.
IV · Evidence
Every measurement at this target
Each row links to the ChEMBL assay it came from.
Equilibrium binding constants 7
Ki and Kd — a concentration at equilibrium. Directly comparable across rows at the same target.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | Ki | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
Functional readouts 17
IC₅₀, EC₅₀, AC₅₀ and potency. Assay-dependent, and not interchangeable with a binding constant.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1909131 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
| Prostaglandin G/H synthase 2 | Enzymes | AC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5291870 |
Other measurements 2
Everything else ChEMBL recorded for this compound — percentage inhibition, efficacy, half-life, cytotoxicity. Reported in the assay's own units, which is why no value is converted here.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 | Enzymes | Inhibition | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1014033 |
| Prostaglandin G/H synthase 2 | Enzymes | Inhibition | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1014033 |